Evidence map›Paper›PMID 31921418›Full record

ArticleArchives of public health = Archives belges de sante publique2020

Prioritising the development of severity distributions in burden of disease studies for countries in the European region.

Grant M A Wyper, Ian Grant, Eilidh Fletcher, Neil Chalmers, Gerry McCartney, Diane L Stockton

Erratum issuedAbstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Recommendations to plan a national burden of disease study.Archives of public health = Archives belges de sante publique · 2021
    Article
  10. Conducting national burden of disease studies in small countries in Europe- a feasible challenge?Archives of public health = Archives belges de sante publique · 2021
    Article
  11. Article
  12. Article
  13. Reflections on key methodological decisions in national burden of disease assessments.Archives of public health = Archives belges de sante publique · 2020
    Article
  14. Article
  15. Article
  16. Population vulnerability to COVID-19 in Europe: a burden of disease analysis.Archives of public health = Archives belges de sante publique · 2020
    Article
  17. History and development of national burden of disease assessment in Australia.Archives of public health = Archives belges de sante publique · 2020
    Article
  18. Measuring disability-adjusted life years (DALYs) due to low back pain in Malta.Archives of public health = Archives belges de sante publique · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Grant M A WyperPublic Health Science Directorate, NHS Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow, Scotland G2 6QE.ORCID 0000-0003-2854-5822
Ian Grant2Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, Scotland EH12 9EB.
Eilidh Fletcher2Information Services Division, NHS National Services Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, Scotland EH12 9EB.
Neil ChalmersPublic Health Science Directorate, NHS Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow, Scotland G2 6QE.
Gerry McCartneyPublic Health Science Directorate, NHS Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow, Scotland G2 6QE.
Diane L StocktonPublic Health Science Directorate, NHS Health Scotland, Meridian Court, 5 Cadogan Street, Glasgow, Scotland G2 6QE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severity distributions are a means of summarising the range of health loss suffered to disease which enables estimates of disease occurrence to be paired with disability weights to estimate Years Lost to Disability (YLD) in burden of disease studies. There is a lack of current data exploring severity distributions, which has led to the Global Burden of Disease (GBD) study relying on using the same severity distributions across countries and regions across the world. This is also largely true for some national studies, although there are exceptions. Recent evidence has raised concerns that severity distributions are unlikely to be generalisable as major differences arise when using country-specific data to develop severity distributions. These issues raise uncertainties over interpreting YLD estimates, particularly if they are being used to develop and influence policies and to determine priorities across diseases and populations. It is clear that GBD researchers and those carrying out national studies need to work towards ensuring that estimates are based upon country-specific data, and, if possible, that the impact of assumptions are fully tested and understood. There is a lack of strategy about if, where, and how, this could be achieved, particularly around how efforts should be prioritised. This commentary advocates and presents a possible strategic approach to better understanding how efforts may be best placed.

Indexed as

Burden of diseaseDALYEBODNGBDSBODSeverity distributionSummary measures of population healthYLD

Identifiers

PMID31921418
PMCPMC6950931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.